Target Audience:

• Representatives of the Commission for HTA, Bulgarian Pharmaceutical Union, Faculties of Public Health in Medical Universities, National Council for Pricing and Reimbursement, Members of working groups for HTA, representatives of NIHF;
• Members of Scientific Society of Healthcare Management, ArPharm ;
• Industry representatives;
• Specialists, professors, students and postgraduates from Faculties of Health Management and Pharmacy.

Main Topics:

• HTA in Bulgaria and EU – current trends and development;
• HTA – principles and practice;
• Specific requirements on the information for informative HTA;
• Unsolved issues and consequences from inappropriate methodologies;
• Good practices sharing;
• HTA in rare diseases;
• HTA for IVD;
• HTA for companion diagnostics;
• The role of HTA for better patients’ access to personalized medicine;
• Practical examples sharing